NFE2L2 and central nervous system cancer: An NRF2 deficiency also worsened inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy [119], increased Alzheimer’s disease (AD)-mediated cognitive decline [120], and significantly attenuated the self-renewal of glioma stem cells [121].